Amphiregulin is an EGFR ligand that is frequently overexpressed in human gastric cancer and promotes epithelial proliferation and survival, making its loss an interesting paradoxical model for studying growth factor dependencies (Jiang et al., 2019; Yasumoto et al., 2011). Here, AREG is linked to gastric cancer.